Clinical trial
A Multicentre, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and the Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis and Early Stage Acute Liver Failure
NCT01318525 is registered in ClinicalTrials.gov with Alfact Innovation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and the Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis and Early Stage Acute Liver Failure
- Lead sponsor
- Alfact Innovation
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 31, 2010
- Completion date
- September 30, 2012
- Enrollment
- 60 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.